Join
Live feed
·
INSIDERFilingvia Quantisnow
Arbutus Biopharma Corporation logo

Chief Financial Officer Hastings David C sold $72,827 worth of shares (22,183 units at $3.28), decreasing direct ownership by 12% to 159,724 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ABUS· Arbutus Biopharma Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABUS (Arbutus Biopharma Corporation) and more on Quantisnow.